Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-00796-4, published online 01 November 2021
The original version of this Article contained an error in Figure 2, where the dashed vertical line located at the label ‘Adjusted Hazard Ratio for Venous Thromboembolism Event’ inadvertently continued and covered the x-axis label ‘1’ in panel (A) and panel (B).
Furthermore, the order of the Figures was incorrect. Figures 3 and 4 were published as Figure 4 and 3. The Figure legends were correct at the time of publication.
The original Figure 2, 3 and 4 and accompanying legends appear below.
Adjusted hazard ratios for primary venous thromboembolism for common medications and non-cancer illnesses. Shown are the adjusted hazard ratios for primary venous thromboembolic events for two factors of interest: common medications (A) and non-cancer illnesses (B). All estimates were adjusted for all nine established risk factors and the first four principal components of ancestry. The I bars represent 95% confidence intervals.
Model performance of a genetic, clinical, and combined score. (A) Shows the density of the polygenic risk score stratified by the 50th, 75th, 90th, 95th, 99th and 99.5th percentiles. (B) Shows the odds ratio for each polygenic risk score percentile. (C) Shows the concordance values, derived from Fine-Gray models, for the De Haan, genetic, clinical, and combined scores. The concordance of the combined model is significantly higher than the concordance of each of the other models (P < 0.001). The I bars represent 95% confidence intervals.
Prediction of venous thromboembolism. (A) and (B) Show the rates of venous thromboembolism derived from Fine-Gray models for the genetic and clinical score, respectively. (C) Shows 10-year event rates for venous thromboembolism, stratified by both the clinical score and genetic score. The I bars represent 95% confidence intervals.
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kolin, D.A., Kulm, S. & Elemento, O. Publisher Correction: Prediction of primary venous thromboembolism based on clinical and genetic factors within the U.K. Biobank. Sci Rep 11, 23364 (2021). https://doi.org/10.1038/s41598-021-02115-3
Published:
DOI: https://doi.org/10.1038/s41598-021-02115-3
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
